Use and benefits of nonsteroidal anti-inflammatory drugs

American Journal of Medicine

Volumn 104, Issue 3 A, 1998, Pages

  Brooks, Peter ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; IBUPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PYRAZOLE DERIVATIVE; SALICYLIC ACID;

CONFERENCE PAPER; DOSE RESPONSE; DRUG COMPETITION; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; GASTROINTESTINAL TOXICITY; HUMAN; INFLAMMATION; LIVER TOXICITY; NEPHROTOXICITY; NEUROTOXICITY; OSTEOARTHRITIS; PLASMA HALF LIFE; PRIORITY JOURNAL; RHEUMATIC DISEASE; URINARY EXCRETION;

EID: 0032579897     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00204-0     Document Type: Conference Paper

References (30)

1. Girgis L, Brooks PM. Non-steroidal antiinflammatory drugs: differential use in older patients. Drugs Ageing. 1994;4:101-112.
2. March L, Brooks P. Arthritis: the hidden disability. Med J Aust 1993;158:369-370.
3. Paulus HE. FDA Arthritis Advisory Committee Meeting: post marketing surveillance of non-steroidal anti-inflammatory drugs. Arthritis Rheum. 1985;28:1168-1169.
4. McCarthy DM. Non-steroidal anti-inflammatory drug-induced ulcers: management by traditional therapies. Gastroenterology. 1989;96:662-674.
5. Day RO, Henry DA, Muirden KD, et al. Non-steroidal anti-inflammatory drug-induced upper gastrointestinal haemorrhage and bleeding. Med J Aust. 1992;157:810-812.
6. Fröhlich JC. Prostaglandin endoperoxide synthase isoenzymes: the clinical relevance of selective inhibition. Ann Rheum Dis. 1995;54:942-943.
7. Brooks PM, Day RO. NSAID - differences and similarities. N Engl J Med. 1991;324:1716-1725.
8. Williams KM, Day RO, Knihinicki RD, Duffield A. The stereo selective uptake of ibuprofen enantiomers in man. Biochem Pharmacol. 1986;35:3403-3405.
9. Dieppe P, Cushnaghan J, Jasani MK, et al. A two year placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol. 1993;32:595-600.
10. Williams HJ, Ward JR, Egger MJ, et al. Comparison of naproxen and acetaminophen in a two year study of treatment of osteoarthritis of the knee. Arthritis Rheum. 1993; 36:1196-1206.
11. March LM, Irwig L, Schwarz J, et al. N-of-1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ. 1994;309:1041-1046.
12. Seideman P, Melander A. Equianalgesic effects of paracetamol and indomethacin in rheumatoid arthritis. Br J Rheumatol. 1988;27:117-122.
13. Johnson AG, Day RO. The problems and pitfalls of NSAID therapy in the elderly (Part V). Drugs Ageing. 1991;1:130-143.
14. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal anti-inflammatory drugs. J Rheumatol. 1985;12:13-20.
15. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal anti-inflammatory drugs (2). J Rheumatol. 1985;12: 347-353.
16. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal anti-inflammatory drugs (3). J Rheumatol. 1985;12: 562-567.
17. O'Brien WM, Bagby GF. Rare adverse reactions to nonsteroidal anti-inflammatory drugs (4). J Rheumatol. 1985;12: 785-790.
18. Houston MC. Non-steroidal anti-inflammatory drugs and antihypertensives. Am J Med. 1991;90(suppl 5A):42S-47S.
19. Friedman PL, Brown Jr EJ, Gunther S, et al. Coronary vasoconstrictor effect of indomethacin in patients with coronary artery disease. N Engl J Med 1981;305:1171-1175.
20. Murray MD, Brater DC. Adverse effects of non-steroidals on renal function. Ann Intern Med. 1990;112:559-560.
21. Roth SH. NSAID and gastropathy: a rheumatologist's view. J Rheumatol. 1988;15:912-919.
22. Griffin MR, Piper JM, Daugherty JR, et al. Non-steroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med. 1991;114: 257-263.
23. Langman MJS, Weil J, Wainwright P, et al. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet. 1994;343:1075-1078.
24. García Rodríguez LA, Jick H. Risk of upper gastrointestinal bleeding and perforation associates with individual nonsteroidal anti-inflammatory drugs. Lancet. 1994;343:769-772.
25. García Rigríguez LA. Variability in risk of gastrointestinal complications with different NSAIDs. Am J Med. 1998; 104(3A):30S-34S.
26. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of non-steroidal anti-inflammatory drugs: a metaanalysis. Ann Intern Med. 1991;115:787-796.
27. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of non-steroidal anti-inflammatory drugs. Ann Intern Med. 1991;114:735-740.
28. McManus P, Primrose JG, Newry DA, et al. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. Med J Aust. 1996;164:589-592.
29. Hawkey CJ. Future treatment for arthritis: new NSAIDs, NO NSAIDs, or no NSAIDs? Gastroenterology. 1995;109:614-616.
30. Sutters C, Keat A, Cant A. Improving prescribing of nonsteroidal anti-inflammatory drugs in hospital: an educational approach. Br J Rheumatol. 1993;32:618-622.